Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes

by Beatriz Tavira, Hugo Barcenilla, Jeannette Wahlberg, Peter Achenbach, Johnny Ludvigsson, Rosaura Casas
Published 2018-01-01

Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes

by Hugo Barcenilla, Linda Åkerman, Mikael Pihl, Johnny Ludvigsson, Johnny Ludvigsson, Rosaura Casas
Published 2019-05-01

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

by Rosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, Jeanette Wahlberg, Jeanette Wahlberg, Peter Achenbach, Johnny Ludvigsson, Johnny Ludvigsson
Published 2020-10-01

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets

by Louise Magnusson, Louise Magnusson, Hugo Barcenilla, Mikael Pihl, Sophie Bensing, Daniel Espes, Daniel Espes, Per-Ola Carlsson, Per-Ola Carlsson, Rosaura Casas
Published 2020-02-01